Tyrosine phosphorylation of mitogen-activated protein kinases is necessary for activation of murine macrophages by natural and synthetic bacterial products

Journal of Experimental Medicine

Volumn 177, Issue 4, 1993, Pages 1071-1077

  Dong, Zhongyun ^a   Qi, Xiaoxia ^a   Fidler, Isaiah J ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; MITOGENIC AGENT; PROTEIN KINASE; TUMOR NECROSIS FACTOR ALPHA; TYROSINE;

ANIMAL CELL; ARTICLE; CHROMATOGRAPHY; DOWN REGULATION; ENZYME ACTIVITY; FEMALE; IMMUNOBLOTTING; IMMUNOPRECIPITATION; LIGAND BINDING; MACROPHAGE; MACROPHAGE ACTIVATION; MOUSE; NONHUMAN; PHOSPHORYLATION; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

AMINO ACID SEQUENCE; ANIMAL; CA(2+)-CALMODULIN DEPENDENT PROTEIN KINASE; CELLS, CULTURED; ENZYME ACTIVATION; KINETICS; LIPOPOLYSACCHARIDES; MACROPHAGE ACTIVATION; MACROPHAGES; MICE; MICE, INBRED C3H; MOLECULAR SEQUENCE DATA; OLIGOPEPTIDES; PEPTIDE FRAGMENTS; PHOSPHORYLATION; PROTEIN KINASES; SIGNAL TRANSDUCTION; SUPPORT, U.S. GOV'T, P.H.S.; TUMOR NECROSIS FACTOR; TYROSINE;

EID: 0027474842     PISSN: 00221007     EISSN: 15409538     Source Type: Journal    
DOI: 10.1084/jem.177.4.1071     Document Type: Article

References (29)

1. Fidler, I.J. 1985. Macrophages and metastasis: a biological approach to cancer therapy. Cancer Res. 45:4714.
2. Utsugi, T., A. Nii, D. Fan, C.C. Pak, Y. Denkins, P. van Hoo-gevest, and I.J. Fidler. 1991. In situ activation of mouse macrophages and therapy of spontaneous renal cell cancer metastasis by liposomes containing the lipopeptide CGP 31362. Cancer Immunol. Immunother. 33:285.
3. Nathan, C.F. 1987. Secretory products of macrophages. J. Clin. Invest. 79:319.
4. Drysdale, B.-E., R.A. Yapundich, M.L. Shin, and H.H. Shin. 1987. Lipopolysaccharide-mediated macrophage activation: the role of calcium in the generation of tumoricidal activity. J. Immunol. 138:951.
5. Novotney, M., Z.L. Chang, H. Uchiyama, and T. Suzuki. 1991. Protein kinase C in tumoricidal activation of mouse macrophage cell lines. Biochemistry. 30:5597.
6. Jakway, J.P., and A.L. DeFranco. 1986. Pertussis toxin inhibition of B cell and macrophage responses to bacterial lipopolysaccharide. Science (Wash.). 234:743.
7. Glaser, K.B., R. Asmis, and E.A. Dennis, 1990. Bacterial lipopolysaccharide priming of P388D1 macrophage-like cells for enhanced arachidonic acid metabolism. Platelet-activating factor receptor activation and regulation of phospholipase A2. J. Biol. Chem. 265:8658.
8. Forehand, J.R., M.J. Pabst, W.A. Phillips, and R.B. Johnston, Jr. 1989. Lipopolysaccharide priming of human neutrophils for an enhanced respiratory burst. Role of intracellular free calcium. J. Clin. Invest. 83:74.
9. Dong, Z., S. Lu, and Y. Zhang. 1989. Effects of pretreatment with protein kinase C activators on macrophage activation for tumor cytotoxicity, secretion of tumor necrosis factor, and its mRNA expression. Immunobiology. 179:382.
10. Dong, Z., C.A. O’Brian, and I.J. Fidler. 1993. Activation of tumoricidal properties in macrophages by lipopolysaccharide and interferon gamma is mediated by tyrosine-protein kinase activity. J. Leuk. Biol. 53:53.
11. Thomas, G. 1992. MAP kinase by any other name smells just as sweet. Cell. 68:3.
12. Anderson, N.G., J.L. Maller, N.K. Tonks, and T.W. Sturgill. 1990. Requirement for integration of signals from two distinct phosphorylation pathways for activation of MAP kinase. Nature (Lond.). 343:651.
13. 3HJHeJ mice. J. Immunol. 120:422.
14. Chedid, L., M. Parant, C. Damais, F. Parant, D. Juy, and A. Galelli. 1976. Failure of endotoxin to increase nonspecific resistance to infection of lipopolysaccharide low-responder mice. Infect. Immun. 13:722.
15. Saiki, I., and I.J. Fidler. 1985. Synergistic activation by recombinant mouse interferon-gamma and muramyl dipeptide of tumoricidal properties in mouse macrophages. J. Immunol. 135:684.
16. Weinstein, S.L., M.R. Gold, and A.L. DeFranco. 1991. Bacterial lipopolysaccharide stimulates protein tyrosine phosphorylation in macrophages. Proc. Natl. Acad. Sei. USA. 88:4148.
17. Anderson, N.G., E. Kilgour, and T.W. Sturgill. 1991. Activation of mitogen-activated protein kinase in BCjHl muocytes by fluoroaluminate. J. Biol. Chem. 266:10131.
18. Clark-Lewis, I., J.S. Sanghera, and S.L. Pelech. 1991. Definition of a consensus sequence for peptide substrate recognition by p44mpk, the meiosis-activated myelin basic protein kinase. J. Biol. Chem. 266:15180.
19. Seger, R., N.G. Ahn, T.G. Boulton, G.D. Yancopoulos, N. Panayotatos, E. Radziejewska, L. Ericsson, R.L. Bratlein, M.H. Bobb, and E.G. Krebs. 1991. Microtubule-associated protein 2 kinases, ERK1 and ERK2, undergo autophosphorylation on both tyrosine and threonine residues: implications for their mechanism of activation. Proc Natl. Acad. Sci. USA. 88:6142.
20. Glass, D.B., H.C. Cheng, L. Mende-Mueller, J. Reed, and D.A. Walsh. 1989. Primary structural determinants essential for potent inhibition of cAMP-dependent protein kinase by inhibitory peptides corresponding to the active portion of the heat-stable inhibitor. J. Biol. Chem. 264:8802.
21. Ray, L.B., and T.W. Sturgill. 1987. Rapid stimulation by insulin of a serineJthreonine kinase in 3T3-L1 adipocytes that phosphorylates microtubule-associated protein 2 in vitro. Proc. Natl. Acad. Sci. USA. 84:1502.
22. Wright, S.D., R.A. Ramos, P.S. Tobias, R.J. Ulevitch, and J.C. Mathison. 1991. CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science (Wash. DC). 249:1431.
23. Gotoh, Y., K. Moriyama, S. Matsuda, E. Okumura, T. Kishimoto, H. Kawasaki, K. Suzuki, T. Yahara, H. Sakai, and E. Nishida. 1991. Xenopus M phase MAP kinase: isolation of its cDNA and activation by MPF. EMBO (Eur. Mol. Biol. Organ.) J. 10:2661.
24. Matsuda, S., H. Kosako, K. Takenaka, H. Sakai, T. Akiyama, Y. Gotoh, and E. Nishida. 1992. Xenopus MAP kinase activator: identification and function as a key intermediate in the phosphorylation cascade. EMBO (Eur. Mol. Biol. Organ.) J. 11:973.
25. Gilligan, A., S. Bushmeyer, and B.B. Knowles. 1992. Variation in EGF-induced EGF receptor downregulation in human hepatoma-derived cell lines expressing different amounts of EGF receptor. Exp. Cell Res. 200:235.
26. Bartsch, H.H., K. Pfizenmaier, A. Hanusch, P. Scheurich, U. Ucer, and G.A. Nagel. 1989. Sequential therapy with recombinant interferons gamma and alpha in patients with unfavorable prognosis of chronic myelocytic leukemia: clinical responsiveness to recombinant IFN-a correlates with the degree of receptor downregulation. Int. J. Cancer. 43:235.
27. Fogler, W.E., J. Talmadge, and I.J. Fidler. 1983. The activation of tumoricidal properties in macrophages of endotoxin responder and nonresponder mice by liposome-encapsulated immunomodulators. J. Reticuloendothei. Soc. 33:165.
28. Perera, P.Y., T. Chen, D.C. Morrison, and S.N. Vogel. 1992. Detection and analysis of the 8-kD lipopolysaccharide receptor in macrophages derived from Lpsn and Lpsd mice. J. Leukocyte Biol. 51:501.
29. Weinstein, S.L., J.S. Sanghera, K. Lemke, A.L. DeFranco, and S.L. Pelech. 1992. Bacterial lipopolysaccharide induces tyrosine phosphorylation and activation of mitogen-activated protein kinases in macrophages. J. Biol. Chem. 267:14955.